FSPHX
Price
$30.12
Change
-$0.01 (-0.03%)
Updated
Nov 18 closing price
Net Assets
6.22B
LHCQX
Price
$22.11
Change
+$0.10 (+0.45%)
Updated
Nov 18 closing price
Net Assets
8.81M
Interact to see
Advertisement

FSPHX vs LHCQX

Header iconFSPHX vs LHCQX Comparison
Open Charts FSPHX vs LHCQXBanner chart's image
Fidelity Select Health Care
Price$30.12
Change-$0.01 (-0.03%)
VolumeN/A
Net Assets6.22B
Lord Abbett Health Care R3
Price$22.11
Change+$0.10 (+0.45%)
VolumeN/A
Net Assets8.81M
FSPHX vs LHCQX Comparison Chart in %
View a ticker or compare two or three
VS
FSPHX vs. LHCQX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSPHX is a Hold and LHCQX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 6.22B vs. LHCQX (8.81M). LHCQX pays higher dividends than FSPHX: LHCQX (0.31) vs FSPHX (0.02). FSPHX was incepted earlier than LHCQX: FSPHX (44 years) vs LHCQX (6 years). LHCQX (3.59) is less costly to investors than FSPHX (0.63). LHCQX is a more actively managed with annual turnover of: 88.00 vs. FSPHX (40.00). FSPHX (0) and LHCQX (0) have matching initial minimum investment requirements. LHCQX annual gain was more profitable for investors over the last year : 15.13 vs. FSPHX (0.35). LHCQX return over 5 years is better than : 7.82 vs. FSPHX (-8.45).
FSPHXLHCQXFSPHX / LHCQX
Total Expense Ratio0.631.2849%
Annual Report Gross Expense Ratio0.633.5918%
Fund Existence44 years6 years-
Gain YTD10.56916.57864%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets6.22B8.81M70,564%
Annual Yield % from dividends0.020.315%
Returns for 1 year0.3515.132%
Returns for 3 years10.5130.5034%
Returns for 5 years-8.457.82-108%
Returns for 10 years39.39N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SPMHX8.480.01
+0.12%
Invesco SteelPath MLP Alpha R5
PEMGX42.33N/A
N/A
Principal MidCap A
BRUFX564.44N/A
N/A
Bruce
REMVX11.11N/A
N/A
RBC Emerging Markets Value Equity I
CVTCX55.08-0.41
-0.74%
Calamos Growth & Income C